Dina L. Masi - 28 Nov 2023 Form 4 Insider Report for INTEGRATED BIOPHARMA INC (INBP)

Role
Chief Financial Officer
Signature
/s/ Dina L Masi
Issuer symbol
INBP
Transactions as of
28 Nov 2023
Net transactions value
$0
Form type
4
Filing time
29 Nov 2023, 17:14:37 UTC
Previous filing
21 Sep 2023
Next filing
25 Nov 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INBP Stock Option (right to buy) Award $0 +150,000 $0.000000 150,000 28 Nov 2023 Common Stock 150,000 $0.2400 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable in three equal annual installments with the first installment vesting on November 28, 2024.